Influential factors in the adherence and abandonment of preventive therapy for latent tuberculosis infection in patients with HIV

被引:0
作者
Bedoya Serna, Beatriz Eugenia [1 ]
机构
[1] Corp Invest Biol, Medellin, Colombia
来源
ARCHIVOS DE MEDICINA | 2019年 / 19卷 / 01期
关键词
HIV; latent tuberculosis; chemoprevention; FAILURE; PREDICTORS; ADULTS; TRIAL;
D O I
10.30554/archmed.19.1.2791.2019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: to describe the factors that influence the lack of adherence to the treatment of the latent tuberculosis infection. Materials and methods: retrospective and descriptive study in people living with the human immunodeficiency virus treated in a health institution of Medellin, Colombia. Results: 45% of patients presented adherence problems such as interruptions less than 30 days or loss of follow-up, the statistical significance (p < 0.05) was presented in the variables of adverse effects and adherence to antiretroviral treatment. Conclusion: adverse effects to treatment and adherence to antiretroviral therapy are associated with problems of adherence to preventive treatment of latent tuberculosis infection.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Treatment of Latent Tuberculosis Infection in HIV: Shorter or Longer?
    Person, Anna K.
    Sterling, Timothy R.
    CURRENT HIV/AIDS REPORTS, 2012, 9 (03) : 259 - 266
  • [22] Facilitators and barriers for tuberculosis preventive treatment among patients with latent tuberculosis infection: a qualitative study
    Manoharan, Anusha
    Farhana, H. Siti Nur
    Manimaran, K.
    Khoo, Ee Ming
    Koh, Wen Ming
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [23] Facilitators and barriers for tuberculosis preventive treatment among patients with latent tuberculosis infection: a qualitative study
    Anusha Manoharan
    H. Siti Nur Farhana
    K. Manimaran
    Ee Ming Khoo
    Wen Ming Koh
    BMC Infectious Diseases, 23
  • [24] Adherence to tuberculosis preventive therapy measured by urine metabolite testing among people with HIV
    Kendall, Emily A.
    Durovni, Betina
    Martinson, Neil A.
    Cavalacante, Solange
    Masonoke, Katlego
    Saraceni, Valeria
    Lebina, Limakatso
    Efron, Anne
    Cohn, Silvia
    Chon, Sandy
    Chaisson, Richard E.
    Dowdy, David W.
    Golub, Jonathan E.
    AIDS, 2020, 34 (01) : 63 - 71
  • [25] Ability of preventive therapy to cure latent Mycobacterium tuberculosis infection in HIV-infected individuals in high-burden settings
    Houben, Rein M. G. J.
    Sumner, Tom
    Grant, Alison D.
    White, Richard G.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (14) : 5325 - 5330
  • [26] Abandonment of Treatment for Latent Tuberculosis Infection and Socioeconomic Factors in Children and Adolescents: Rio De Janeiro, Brazil
    Cabral Mendonca, Angela Marcia
    Kritski, Afranio Lineu
    Poirot Land, Marcelo Gerardin
    Sant'Anna, Clemax Couto
    PLOS ONE, 2016, 11 (05):
  • [27] Effect of HIV-infection on QuantiFERON-plus accuracy in patients with active tuberculosis and latent infection
    Petruccioli, Elisa
    Chiacchio, Teresa
    Navarra, Assunta
    Vanini, Valentina
    Cuzzi, Gilda
    Cimaglia, Claudia
    Codecasa, Luigi Ruffo
    Pinnetti, Carmela
    Riccardi, Niccolo
    Palmieri, Fabrizio
    Antinori, Andrea
    Goletti, Delia
    JOURNAL OF INFECTION, 2020, 80 (05) : 536 - 546
  • [28] Is systematic screening and treatment for latent tuberculosis infection in HIV patients useful in a low endemic setting?
    Maniewski, Ula
    Payen, Marie-Christine
    Delforge, Marc
    De Wit, Stephane
    ACTA CLINICA BELGICA, 2017, 72 (04) : 238 - 241
  • [29] Preventive therapy for tuberculosis in HIV infected individuals
    Padmapriyadarsini, C
    Swaminathan, S
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2005, 121 (04) : 415 - 423
  • [30] Isoniazid preventive therapy and 4-year incidence of pulmonary tuberculosis among HIV-infected Thai patients
    Khawcharoenporn, T.
    Apisarnthanarak, A.
    Manosuthi, W.
    Sungkanuparph, S.
    Mundy, L. M.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (03) : 336 - 341